Bech Katrine Tholstrup, Seyedi Jian Fernandes, Schulz Mette, Poulsen Frantz Rom, Pedersen Christian Bonde
Department of Neurosurgery, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense, Denmark; Clinical Institute, University of Southern Denmark, Odense, Denmark; OPEN Odense Patient Data Explorative Network, J. B. Winsløws Vej 9 a, Odense Denmark.
Department of Neurosurgery, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense, Denmark; Clinical Institute, University of Southern Denmark, Odense, Denmark; OPEN Odense Patient Data Explorative Network, J. B. Winsløws Vej 9 a, Odense Denmark.
Clin Neurol Neurosurg. 2018 Jun;169:185-191. doi: 10.1016/j.clineuro.2018.04.024. Epub 2018 Apr 23.
To identify risk factors for developing seizures pre- and postoperatively in low- and high-grade gliomas.
282 patients undergoing neurosurgical tumor resection between 2013-2015 were included in the present single-center retrospective cohort study. Seizure incidences according to various variables were described. Univariate and multivariate logistic regression analyses were performed to identify significant risk factors for both pre- and postoperative seizures.
37.6% of patients presented with seizures before surgery, 18.4% developed seizures in the postoperative course, and 55.0% had no record of seizures pre- or postoperatively. Focal, cognitive, and other symptoms, tumors located in a non-eloquent area, and tumors ≥ 40 mm in diameter were found to be associated with a reduced risk of preoperative seizures, whereas hypertension or no comorbidity posed an increased risk. The presence of seizures pre- or perioperatively (≤ 24 h before and after surgery), and tumors located in the thalamus were associated with an increased risk of seizures in the postoperative course.
Predictors for pre- and postoperative seizures identified in this study should be taken into account and integrated into the present knowledge, when determining patients at increased risk of developing seizures. Future prospective studies investigating the efficacy of prophylactic antiepileptic therapy in subgroups of glioma patients are needed before applied into clinical practice.
确定低级别和高级别胶质瘤患者术前和术后发生癫痫的危险因素。
本单中心回顾性队列研究纳入了2013年至2015年间接受神经外科肿瘤切除术的282例患者。描述了根据各种变量的癫痫发作发生率。进行单因素和多因素逻辑回归分析,以确定术前和术后癫痫发作的显著危险因素。
37.6%的患者术前出现癫痫发作,18.4%的患者在术后病程中出现癫痫发作,55.0%的患者术前或术后无癫痫发作记录。局灶性、认知性和其他症状、位于非功能区的肿瘤以及直径≥40mm的肿瘤与术前癫痫发作风险降低相关,而高血压或无合并症则增加了风险。术前或围手术期(手术前后≤24小时)出现癫痫发作以及位于丘脑的肿瘤与术后癫痫发作风险增加相关。
在确定癫痫发作风险增加的患者时,应考虑本研究中确定的术前和术后癫痫发作的预测因素,并将其纳入现有知识体系。在应用于临床实践之前,需要未来进行前瞻性研究,调查预防性抗癫痫治疗在胶质瘤患者亚组中的疗效。